Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Global HealthBOM:543654 -0.04%96 Dividend Yield % is 0.04% as of Aug. 26, 2026, which is at its 10-year median of 0.04. GuruFocus rates BOM:543654 with a GF Score™ of 96/100 and a GF Value™ of ₹1,562.98 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 277 Healthcare Providers & Services companies, Global Health ranks worse than 100% on this metric.
As of today (2026-08-26), the Trailing Annual Dividend Yield of Global Health is 0.04%.
The historical rank and industry rank for Global Health's Dividend Yield % or its related term are showing as below:
BOM:543654'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.03 Med: 0.04 Max: 0.05
Current: 0.04
During the past 7 years, the highest Dividend Yield of Global Health was 0.05%. The lowest was 0.03%. And the median was 0.04%.
BOM:543654's Dividend Yield % is ranked worse than 100% of 277
companies
in the Healthcare Providers & Services industry
Industry Median: 2.28
vs BOM:543654: 0.04
Global Health (BOM:543654) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Global Health's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543654 vs HCA, THC, DVA: Dividend Yield % Comparison
For the Medical Care Facilities subindustry, Global Health's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Health Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Health's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Global Health's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Global Health Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 0.500000
2026-08-14
2026-08-14
2026-10-15
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Global Health's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.5
/
1404.70
=
0.04 %
Current Share Price is ₹1404.70. Global Health's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹0.5.
Global Health's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.5
/
1404.70
=
0.04 %
Current Share Price is ₹1404.70. Global Health's Dividends per Share for the forward twelve months is calculated as ₹0.5 * 1 = ₹0.5.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Health (BOM:543654) has a Dividend Yield % of 0.04% as of Aug. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Global Health and its competitors. This is near median its historical median of 0.04. Over the past decade, Global Health's Dividend Yield % has ranged from 0.03 to 0.05. According to the industry distribution chart, Global Health ranks #277 out of 277 companies in the Healthcare Providers & Services industry.
Is Global Health's Dividend Yield % too high?
Global Health's current Dividend Yield % of 0.04% is near median its 10-year median of 0.04. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.05. The Healthcare Providers & Services industry median Dividend Yield % is 2.28. Global Health's value of 0.04% is 98.2% below this industry median. Based on the distribution chart, Global Health ranks #277 out of 277 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Global Health has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Global Health's Dividend Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Global Health ranks #277 out of 277 companies for Dividend Yield %. This places Global Health in the lower half of its industry. The industry median Dividend Yield % is 2.28. Global Health's value of 0.04% is 98.2% below this benchmark. Historically, Global Health's own Dividend Yield % has ranged from 0.03 to 0.05 over the past decade. While the company's 10-year median is 0.04 vs. the industry median of 2.28, Global Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.28, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Global Health's current Dividend Yield % of 0.04% is 98.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Global Health and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Health's current Dividend Yield % is 0.04%, which is near median its own 10-year median of 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Health stock overvalued right now?
Based on GuruFocus' analysis, Global Health (BOM:543654) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,562.98, compared to a current price of ₹1,404.70 — trading 10.1% below its estimated fair value. The current Dividend Yield % is 0.04%, which is near median its 10-year median of 0.04 and 98.2% below the Healthcare Providers & Services industry median of 2.28. Global Health's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Global Health (BOM:543654), the current Dividend Yield % is 0.04% as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Global Health (BOM:543654) Overvalued in 2026?
Based on GuruFocus' analysis, Global Health stock appears to be undervalued.
The current stock price of ₹1,404.70 is trading 10.1% below its estimated GF Value™ of ₹1,562.98.
GuruFocus considers Global Health to be Modestly Undervalued.
Key valuation signals for BOM:543654:
Dividend Yield %: 0.04% (near median its 10-year median of 0.04)
GF Value™: ₹1,562.98 vs. price of ₹1,404.70 (10.1% below fair value)
Industry Position: 98.2% below the Healthcare Providers & Services median (#277 of 277)
No single metric tells the full story. See the BOM:543654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
96GF Score
Get the complete analysis for BOM:543654
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543654 has been successfully added to your 
